Substance
APOLIZUMAB
Global reference: every product and company linked to this substance.
- cas: 267227-08-7
- ncit: C2228
- unii: G88KCP51RE
apolizumab [INN] · APOLIZUMAB [USAN] · Apolizumab [WHO-DD] · HU-1D10 · HU1D10 · REMITOGEN
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.